Tirzepatide and kidney function: an intriguing and promising observation
- PMID: 36152638
- DOI: 10.1016/S2213-8587(22)00258-3
Tirzepatide and kidney function: an intriguing and promising observation
Conflict of interest statement
I declare no competing interests.
Comment on
-
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial.Lancet Diabetes Endocrinol. 2022 Nov;10(11):774-785. doi: 10.1016/S2213-8587(22)00243-1. Epub 2022 Sep 21. Lancet Diabetes Endocrinol. 2022. PMID: 36152639 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical